Serial 98155042
Live / Registered — Registered (as of 17 Mar 2026)
What this means for you
Registered since 17 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98155042
- Registration number
- 8179070
- Mark type
- Design / logo
- Filed
- 29 Aug 2023
- Published for opposition
- 04 Jun 2024
- Registered
- 17 Mar 2026
- Attorney of record
- Cheryl A. Withycombe
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations to treat infections; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Allergan Pharmaceuticals International Limited, Dublin 17, IE
- Allergan Pharmaceuticals International Limited, Dublin 17, IE
- Allergan Pharmaceuticals International Limited, Dublin 17, IE
Prosecution history
- 17 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 25 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Aug 2025 — USE AMENDMENT FILED
- 17 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 02 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Apr 2025 — SOU EXTENSION 2 GRANTED
- 02 Apr 2025 — SOU EXTENSION 2 FILED
- 01 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jan 2025 — SOU EXTENSION 1 GRANTED
- 11 Jan 2025 — SOU EXTENSION 1 FILED